Detail
| LncRNA Name | RP1130-1 |
| Synonyms | LINC02055, RP1130-1 |
| Region | GRCh38_8:136530798-136984935 Sequence |
| Ensembl | ENSG00000254101 |
| RefSeq | NR_147196 |
| Circulating | ✘ |
| Drug-resisitant | ✘ |
| Prognostic | ✔ |
| MiRNA | ✘ |
| Variant | ✘ |
| TF | ✘ |
| Methylation | ✘ |
| Cancer Name | hepatocellular carcinoma |
| ICD-0-3 | C22.0 M8170/3 |
| Methods | qPCR etc. |
| Sample | HCC tissues, cell lines (HepG2, LO2, Huh7, and SMMC-7721) |
| Expression Pattern | down-regulated |
| Function Description | Expression of LINC RP1130-1 was found to be markedly down-regulated in 51 HCC tissues compared to matching adjacent non-tumor liver tissues. The expression of LINC RP1130-1 was associated with clinical stage, the number of tumors, portal vein tumor thrombus (PVTT), and microvascular invasion (MVI). |
| Pubmed ID | 27773892 |
| Year | 2016 |
| Title | The significance of low levels of LINC RP1130-1 expression in human hepatocellular carcinoma. |
| External Links |
| Links for RP1130-1 | GenBank HGNC lncrnadb Noncode |
| Links for hepatocellular carcinoma | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.